메뉴 건너뛰기




Volumn 49, Issue 1, 2004, Pages 31-37

A method for determining whether hypotension caused by novel compounds in preclinical development results from histamine release

Author keywords

Compound 48 80; Cromolyn; Histamine; Hypotension; Methods; Rat; SC 372

Indexed keywords

ACETAMIDE DERIVATIVE; COMPOUND 48-80; CROMOGLYCATE DISODIUM; HISTAMINE; N [4 [AMINO(IMINO)METHYL]BENZYL] 2 [6 (3 AMINOPHENYL) 5 CHLORO 3 (CYCLOBUTYLAMINO) 2 OXOPYRAZIN 1(2H) YL]ACETAMIDE; THIOBUTABARBITAL; UNCLASSIFIED DRUG;

EID: 0345167241     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2003.08.002     Document Type: Article
Times cited : (3)

References (6)
  • 4
    • 0023108586 scopus 로고
    • Cromolyn sodium: A review of mechanisms and clinical use in asthma
    • Murphy S., Kelly H.W. Cromolyn sodium: A review of mechanisms and clinical use in asthma. Drug Intel. Clin. Pharm. 21:1987;22-35.
    • (1987) Drug Intel. Clin. Pharm. , vol.21 , pp. 22-35
    • Murphy, S.1    Kelly, H.W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.